glatiramer acetate
glatiramer acetate is listed in the FDA National Drug Code directory with 9 NDC codes, marketed under brand names including Glatiramer Acetate, GLATIRAMER ACETATE. Available dosage form: injection, solution.
Drug Details
- Generic Name
- glatiramer acetate
- Brand Names
- Glatiramer Acetate, GLATIRAMER ACETATE
- Application Number
- ANDA213382
- Sponsor
- AJENAT PHARMACEUTICALS LLC
- NDC Codes
- 9
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- GLATIRAMER ACETATE
Indications and Usage
1 INDICATIONS AND USAGE Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults ( 1 ).